cilostazol has been researched along with Injuries, Spinal Cord in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahin, MA | 1 |
| Onan, B | 1 |
| Guler, A | 1 |
| Oztas, E | 1 |
| Uysal, B | 1 |
| Arslan, S | 1 |
| Demirkilic, U | 1 |
| Tatar, H | 1 |
1 other study available for cilostazol and Injuries, Spinal Cord
| Article | Year |
|---|---|
Cilostazol, a type III phosphodiesterase inhibitor, reduces ischemia/reperfusion-induced spinal cord injury.
Topics: Animals; Cilostazol; Male; Phosphodiesterase 3 Inhibitors; Rats; Rats, Wistar; Reperfusion Injury; S | 2011 |